trial · primary record
albuterol inhaler
Lymphangioleiomyomatosis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2027-11-01 |
| Primary endpoint | Greater improvement in lung function with nebulized albuterol. |
| Registry ID | NCT01799538 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:10.987Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01799538
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.